Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs

Drug and Alcohol Dependence

Volumn 128, Issue 1-2, 2013, Pages 104-110

  Silva, Karol ^a,c   Schrager, Sheree M ^b   Kecojevic, Aleksandar ^a   Lankenau, Stephen E ^a  

^a DREXEL UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Non fatal overdose; Nonmedical use of prescription drugs; Prescription drug misuse; Young drug users

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; OPIATE DERIVATIVE; PRESCRIPTION DRUG; TRANQUILIZER;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MISUSE; DRUG OVERDOSE; FAMILY RELATION; FEMALE; HIGH RISK POPULATION; HOSPITAL CARE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL HEALTH CARE; NON FATAL OVERDOSE; ONSET AGE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SOCIAL CLASS; UNITED STATES;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; DRUG OVERDOSE; FEMALE; HUMANS; MALE; PRESCRIPTION DRUGS; PREVALENCE; SOCIOECONOMIC FACTORS; TRANQUILIZING AGENTS;

EID: 84872389419     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.08.014     Document Type: Article

References (62)

1. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 1995, 57:289-300.
2. Biernacki P., Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Soc. Meth. Res. 1981, 10:141-163.
3. Bohnert A.S., Fudalej S., Ilgen M.A. Increasing poisoning mortality rates in the United States, 1999-2006. Public Health Rep. 2010, 125:542-547.
4. Bohnert A.S., Roeder K.M., Ilgen M.A. Suicide attempts and overdoses among adults entering addictions treatment: comparing correlates in a U.S. national study. Drug Alcohol Depend. 2011, 119:106-112.
5. Bohnert A.S., Ilgen M.A., Ignacio R.V., McCarthy J.F., Valenstein M., Blow F.C. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am. J. Psychiatry 2012, 169:64-70.
6. Britton P.C., Wines J.D., Conner K.R. Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug Alcohol Depend. 2010, 107:51-55.
7. Brown B.W., Russell K. Methods correcting for multiple testing: operating characteristics. Statist. Med. 1997, 16:2511-2528.
8. Brugal M.T., Barrio G., De L.F., Regidor E., Royuela L., Suelves J.M. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002, 97:319-327.
9. Burns J.M., Martyres R.F., Clode D., Boldero J.M. Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances. Med. J. Aust. 2004, 181(Suppl. 7):S25-S28.
10. Carpenter M.J., Chutuape M.A., Stitzer M.L. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend. 1998, 53:11-15.
11. Center for Disease Control and Prevention (CDC) Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004-2008. MMWR 2010, 59:705-709.
12. Center for Disease Control and Prevention (CDC) Drug-induced deaths - United States, 2003-2007. MMWR 2011, (Suppl. 60):60-61.
13. Centers for Disease Control and Prevention (CDC) Community-based opioid overdose prevention programs providing naloxone - United States, 2010. MMWR 2012, 61:101-105. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm.
14. Charlson F., Degenhardt L., McLaren J., Hall W., Lynskey M. A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol. Drug Saf. 2009, 18:93-103.
15. Daniulaityte R., Falck R.S., Wang J., Carlson R.G. Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addict Behav. 2009, 34:649-653.
16. Darke S., Ross J. Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992-1996. Addiction 2000, 95:569-573.
17. Darke S., Zador D. Fatal heroin 'overdose': a review. Addiction 1996, 91:1765-1772.
18. Darke S., Ross J., Hall W. Overdose among heroin users in Sydney, Australia. I: Prevalence and correlates of non-fatal overdose. Addiction 1996, 91:405-411.
19. Darke S., Hall W. Heroin overdose: research and evidence-based intervention. J. Urban Health 2003, 80:189-200.
20. Darke S., Hetherington K., Ross J., Lynskey M., Teesson M. Non-injecting route of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev. 2004, 23:177-183.
21. Darke S., Ross J., Mills K., Teesson M., Williamson A., Havard A. Benzodiazepine use among heroin users: baseline use, current use and clinical outcome. Drug Alcohol Rev. 2010, 29:250-255.
22. Evans J.L., Tsui J.I., Hahn J.A., Davidson P.J., Lum P.J., Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am. J. Epidemiol. 2012, 175:302-308.
23. Fairbairn N., Wood E., Stoltz J.A., Li K., Montaner J., Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health 2008, 122:70-78.
24. Farrell M., Neeleman J., Griffiths P., Strang J. Suicide and overdose among opiate addicts. Addiction 1996, 91:321-323.
25. Field A. Discovering Statistics Using SPSS for Windows 2000, Sage Publications, Thousand Oaks, CA.
26. Fleary S.A., Heffer R.W., McKyer E.L. Dispositional, ecological and biological influences on adolescent tranquilizer, Ritalin, and narcotics misuse. J. Adolesc. 2011, 34:653-663.
27. Galea S., Nandi A., Coffin P.O., Tracy M., Markham Piper T., Ompad D., Vlahov D. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J. Addict. Dis. 2006, 25:79-87.
28. Gossop M., Stewart D., Treacy S., Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002, 97:39-47.
29. Hakansson A., Schlyter F., Berglund M. Factors associated with history of non-fatal overdose among opioid users in the Swedish criminal justice system. Drug Alcohol Depend. 2008, 94:48-55.
30. Hall K.M., Irwin M.M., Bowman K.A., Frankenberger W., Jewett D.C. Illicit use of prescribed stimulant medication among college students. J. Am. Coll. Health 2005, 53:167-174.
31. Havens J.R., Oser C.B., Knudsen H.K., Lofwall M., Stoops W.W., Walsh S.L., Leukefeld C.G., Kral A.H. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend. 2011, 115:107-112.
32. Katz N.P., Adams E.H., Chilcoat H., Colucci R.D., Comer S.D., Goliber P., Grudzinskas C., Jasinski D., Lande S.D., Passik S.D., Schnoll S.H., Sellers E., Travers D., Weiss R. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin. J. Pain 2007, 23:648-660.
33. Kaye S., Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction 2004, 99:1315-1322.
34. Kerr T., Fairbairn N., Tyndall M., Marsh D., Li K., Montaner J., Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007, 87:39-45.
35. Kinner S.A., Milloy M.J., Wood E., Qi J., Zhang R., Kerr T. Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addict. Behav. 2012, 37:691-696.
36. Lankenau S.E., Teti M., Silva K., Bloom J.J., Harocopos A., Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int. J. Drug Policy 2012, 23:37-44.
37. Lankenau S.E., Sanders B., Bloom J.J., Hathazi D.S., Alarcon E., Tortu S., Clatts M. Prevalence and patterns of prescription drug misuse among young ketamine injectors. J. Drug Issues 2007, 37:717-736.
38. Latkin C.A., Hua W., Tobin K. Social network correlates of self-reported non-fatal overdose. Drug Alcohol Depend. 2004, 73:61-67.
39. Maloney E., Degenhardt L., Darke S., Nelson E.C. Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlates. Addict. Behav. 2009, 34:723-729.
40. McCabe S.E., Knight J.R., Teter C.J., Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005, 100:96-106.
41. McGregor C., Darke S., Ali R., Christie R. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction 1998, 93:701-711.
42. Nagelkereke N.J.D. A note on a general definition of the coefficient of determination. Biometrika 1991, 78:691-692.
43. Neale J., Robertson M. Recent life problems and non-fatal overdose among heroin users entering treatment. Addiction 2005, 100:168-175.
44. Ochoa K.C., Davidson P.J., Evans J.L., Hahn J.A., Page-Shafer K., Moss A.R. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005, 80:297-302.
45. Paulozzi L.J., Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol. Drug Saf. 2008, 17:997-1005.
46. Paulozzi L.J., Kilbourne E.M., Shah N.G., Nolte K.B., Desai H.A., Landen M.G., Harvey W., Loring L.D. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012, 13:87-95.
47. Pollini R.A., McCall L., Mehta S.H., Vlahov D., Strathdee S.A. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006, 83:104-110.
48. Roy E., Arruda N., Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst. Use Misuse 2011, 46:1142-1150.
49. Robinson J., Sareen J., Cox B.J., Bolton J.M. Role of self-medication in the development of comorbid anxiety and substance use disorders: a longitudinal investigation. Arch. Gen. Psychiatry 2011, 68:800-807.
50. Ross J., Darke S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction 2000, 95:1785-1793.
51. Sansone R.A., Wiederman M.W. The abuse of prescription medications: borderline personality patients in psychiatric versus non-psychiatric settings. Int. J. Psychiatry Med. 2009, 39:147-154.
52. Sherman S.G., Cheng Y., Kral A.H. Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city. Drug Alcohol Depend. 2007, 88:182-187.
53. Substance Abuse Mental Health Services Administration (SAMHSA) Results from the 2009 National Survey on Drug Use and Health. Vol. I: Summary of National Findings 2010, Office of Applied Studies, Rockville, MD, USA, (NSDUH Series H-38A, HHS Publication No. SMA 10-4856). Available at: http://www.samhsa.gov/data/NSDUH/2k9NSDUH/2k9Results.htm (accessed 22.05.12).
54. Substance Abuse and Mental Health Services Administration (SAMHSA), 2010b. The DAWN Report: Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-related Emergency Department Visits. Rockville, MD. Available at: (accessed 22.05.12). http://www.samhsa.gov/data/2k10/dawnsr034edhighlights/edhighlights.htm.
55. Swift W., Maher L., Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in South-western Sydney, Australia. Addiction 1999, 94:71-82.
56. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 2006, Needham Heights, MA, Allyn and Bacon. 5th ed.
57. Teter C.J., Falone A.E., Cranford J.A., Boyd C.J., McCabe S.E. Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administration. J. Subst. Abuse Treat. 2010, 38:292-298.
58. Tobin K.E., Latkin C.A. The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore. J. Urban Health 2003, 80:220-229.
59. Toblin R.L., Paulozzi L.J., Logan J.E., Hall A.J., Kaplan J.A. Mental illness and psychotropic drugs use among prescription drug overdose deaths: a medical examiner chart review. J. Clin. Psychiatry 2010, 71:491-496.
60. Watters J.K., Biernacki P. Targeted sampling: options for the study of hidden populations. Soc. Probl. 1998, 36:416-430.
61. Wines J.D., Saitz R., Horton N.J., Lloyd-Travaglini C., Samet J.H. Overdose after detoxification: a prospective study. Drug Alcohol Depend. 2007, 89:161-169.
62. Xiang Y., Zhao W., Xiang H., Smith G.A. ED visits for drug-related poisoning in the United States, 2007. Am. J. Emerg. Med. 2012, 30:293-301.